Moreover, studies in lung cancer suggested that the CD8/CD4 ratio in patients in the non-metastasis group was remarkably higher, and these patients had a significantly better overall survival rate than patients with a low CD8/CD4 ratio [44, 45]. The gene discussed is CD4; the disease is lung carcinoma.